Status:

RECRUITING

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

Lead Sponsor:

University of Belgrade

Conditions:

Breast Cancer

Eligibility:

FEMALE

45-70 years

Phase:

NA

Brief Summary

This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.

Detailed Description

With 2.1 million new breast cancer (BRC) cases each year globally, BRC is one of the biggest health challenges today. Available anticancer therapies have limited efficacy and are coupled with toxic si...

Eligibility Criteria

Inclusion

  • Age: 45 to 70 years
  • Postmenopausal women
  • Histologically confirmed BRC, stage I to IIIa
  • ER positive /HER2 negative
  • Application of adjuvant hormone therapy with aromase inhibitors: 6 to 30 months
  • Body mass index from 20 to 34.9 kg/m 2
  • Able to understand the requirements of the study and provide written information consent

Exclusion

  • Metastatic or locally advanced disease
  • HER2-positive tumors
  • Presence of other malignant or serious chronic diseases
  • Active infections
  • Previous stroke or heart attack,
  • Rheumatoid arthritis and other types of autoimmune diseases
  • Presence of a significant neurological deficit
  • Dementia
  • Allergy to the ingredients of the dietary preparation or to fish, fish oil and nuts fruits.
  • Allergies to evening primrose oil or other oils containing gamma-linolenic acid (borage, black currant)
  • Use of lipid-lowering drugs (statins, Normolip)
  • Current use of warfarin or other anticoagulants
  • Corticosteroid therapy for the last month
  • Use of dietary supplements based on fish oil, evening primrose, and flaxseed oils, omega 3-6-9 fatty acids, multivitamins with added omega-3 of fatty acids 3 months before the start of the study

Key Trial Info

Start Date :

March 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 30 2026

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06214598

Start Date

March 1 2024

End Date

November 30 2026

Last Update

May 9 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Clinical Hospital Center Bezanijska kosa

Belgrade, Serbia, 11070

2

Center of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, University of Belgrade

Belgrade, Serbia, 11129